SG11201407489TA - Medicine comprising combination of general anesthetic drug and hydrogen - Google Patents
Medicine comprising combination of general anesthetic drug and hydrogenInfo
- Publication number
- SG11201407489TA SG11201407489TA SG11201407489TA SG11201407489TA SG11201407489TA SG 11201407489T A SG11201407489T A SG 11201407489TA SG 11201407489T A SG11201407489T A SG 11201407489TA SG 11201407489T A SG11201407489T A SG 11201407489TA SG 11201407489T A SG11201407489T A SG 11201407489TA
- Authority
- SG
- Singapore
- Prior art keywords
- lllll
- medicine
- llll
- brain
- combination
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 7
- 229940079593 drug Drugs 0.000 title abstract 4
- 239000003193 general anesthetic agent Substances 0.000 title abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000001257 hydrogen Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 title abstract 2
- 102220240796 rs553605556 Human genes 0.000 abstract 5
- 210000004556 brain Anatomy 0.000 abstract 4
- 230000003444 anaesthetic effect Effects 0.000 abstract 2
- 201000001119 neuropathy Diseases 0.000 abstract 2
- 230000007823 neuropathy Effects 0.000 abstract 2
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012125535 | 2012-05-31 | ||
| PCT/JP2013/065094 WO2013180240A1 (fr) | 2012-05-31 | 2013-05-30 | Médicament comportant une combinaison d'un médicament anesthésique général et d'hydrogène |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407489TA true SG11201407489TA (en) | 2014-12-30 |
Family
ID=49673427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407489TA SG11201407489TA (en) | 2012-05-31 | 2013-05-30 | Medicine comprising combination of general anesthetic drug and hydrogen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150079197A1 (fr) |
| EP (1) | EP2857026A4 (fr) |
| JP (1) | JP6168420B2 (fr) |
| KR (1) | KR20150018832A (fr) |
| CN (1) | CN104394873A (fr) |
| AU (1) | AU2013268366A1 (fr) |
| BR (1) | BR112014029260A2 (fr) |
| CA (1) | CA2874579A1 (fr) |
| HK (1) | HK1205450A1 (fr) |
| IL (1) | IL235718A0 (fr) |
| IN (1) | IN2014MN02090A (fr) |
| MX (1) | MX2014014543A (fr) |
| NZ (1) | NZ701553A (fr) |
| RU (1) | RU2014152690A (fr) |
| SG (1) | SG11201407489TA (fr) |
| WO (1) | WO2013180240A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6253029B2 (ja) * | 2015-01-21 | 2017-12-27 | 大陽日酸株式会社 | 麻酔器用取付キット |
| US20180338995A1 (en) * | 2017-05-23 | 2018-11-29 | Perricone Hydrogen Water Company, Llc | Systems and methods for treatments using hydrogen and/or noble gases |
| US11129848B2 (en) * | 2017-08-08 | 2021-09-28 | Perricone Hydrogen Water Company, Llc | Medication enhancement using hydrogen |
| AU2019293044A1 (en) * | 2018-06-29 | 2021-01-21 | John Mansell | Compositions and methods for the treatment of anesthesia-induced neurotoxicity |
| US11123365B2 (en) | 2019-11-18 | 2021-09-21 | Perricone Hydrogen Water Company, Llc | Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof |
| JP7019910B2 (ja) * | 2020-07-21 | 2022-02-16 | ＭｉＺ株式会社 | 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物 |
| CN117861037A (zh) * | 2022-10-11 | 2024-04-12 | 上海氢医医疗科技有限公司 | 氢气吸入治疗自闭症 |
-
2013
- 2013-05-30 NZ NZ701553A patent/NZ701553A/en not_active IP Right Cessation
- 2013-05-30 EP EP13796554.7A patent/EP2857026A4/fr not_active Withdrawn
- 2013-05-30 WO PCT/JP2013/065094 patent/WO2013180240A1/fr active Application Filing
- 2013-05-30 RU RU2014152690A patent/RU2014152690A/ru unknown
- 2013-05-30 JP JP2014518736A patent/JP6168420B2/ja not_active Expired - Fee Related
- 2013-05-30 US US14/397,229 patent/US20150079197A1/en not_active Abandoned
- 2013-05-30 CA CA2874579A patent/CA2874579A1/fr not_active Abandoned
- 2013-05-30 IN IN2090MUN2014 patent/IN2014MN02090A/en unknown
- 2013-05-30 BR BR112014029260A patent/BR112014029260A2/pt not_active Application Discontinuation
- 2013-05-30 AU AU2013268366A patent/AU2013268366A1/en not_active Abandoned
- 2013-05-30 KR KR20147035945A patent/KR20150018832A/ko active Search and Examination
- 2013-05-30 MX MX2014014543A patent/MX2014014543A/es unknown
- 2013-05-30 CN CN201380028933.5A patent/CN104394873A/zh active Pending
- 2013-05-30 SG SG11201407489TA patent/SG11201407489TA/en unknown
-
2014
- 2014-11-16 IL IL235718A patent/IL235718A0/en unknown
-
2015
- 2015-04-16 HK HK15103729.5A patent/HK1205450A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104394873A (zh) | 2015-03-04 |
| EP2857026A4 (fr) | 2015-11-04 |
| JP6168420B2 (ja) | 2017-07-26 |
| AU2013268366A1 (en) | 2015-03-19 |
| EP2857026A1 (fr) | 2015-04-08 |
| NZ701553A (en) | 2016-06-24 |
| JPWO2013180240A1 (ja) | 2016-01-21 |
| RU2014152690A (ru) | 2016-07-20 |
| HK1205450A1 (en) | 2015-12-18 |
| US20150079197A1 (en) | 2015-03-19 |
| CA2874579A1 (fr) | 2013-12-05 |
| KR20150018832A (ko) | 2015-02-24 |
| IL235718A0 (en) | 2015-01-29 |
| IN2014MN02090A (fr) | 2015-09-04 |
| BR112014029260A2 (pt) | 2017-06-27 |
| MX2014014543A (es) | 2015-06-05 |
| WO2013180240A1 (fr) | 2013-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201407489TA (en) | Medicine comprising combination of general anesthetic drug and hydrogen | |
| SG11201807401RA (en) | Therapeutic membrane vesicles | |
| SG11201407009UA (en) | Fe-Pt-BASED SPUTTERING TARGET HAVING NON-MAGNETIC SUBSTANCE DISPERSED THEREIN | |
| SG11201407819UA (en) | Improved methods of cell culture for adoptive cell therapy | |
| SG11201811491YA (en) | Quinazoline and indole compounds to treat medical disorders | |
| SG11201408318RA (en) | Compositions and methods for transmucosal absorption | |
| SG11201804375WA (en) | Compositions and methods for internalizing enzymes | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201407417VA (en) | Encoding and reconstruction of residual data based on support information | |
| SG11201407851RA (en) | Synthesis of pyrrolo [2, 3 - b] pyridines | |
| SG11201406913VA (en) | Text mining system, text mining method, and program | |
| SG11201803169WA (en) | Cellulase variants and polynucleotides encoding same | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201408589RA (en) | Encoding device and encoding method | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201408385TA (en) | Methods of detecting diseases or conditions | |
| SG11201901959YA (en) | Modified stem cell memory t cells, methods of making and methods of using same | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201806652RA (en) | Method for fabricating an object | |
| SG11201408095XA (en) | Fibroblast growth factor 21 proteins | |
| SG11201408303WA (en) | Adhesive compositions of propylene-based and ethylene-based polymers | |
| SG11201901351UA (en) | A patient interface, system and method | |
| SG11201403106SA (en) | Anti-phf-tau antibodies and their uses | |
| SG11201907734XA (en) | Overmolded textile cushion | |
| SG11201402746TA (en) | Electronic substrate housing equipment and electric apparatus |